Subject Expert Committee Of The Central Drugs Standard Control Organisation

Rediff.com » News » Subject Expert Committee Of The Central Drugs Standard Control Organisation

News for Subject Expert Committee Of The Central Drugs Standard Control Organisation

News
Business

Bharat Biotech's Covaxin vaccine cleared by special panel

An expert panel of India's central drug authority on Saturday recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain......

DCGI approves market authorisation for Covovax as Covid booster dose

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or......

Covaxin recommended by expert panel for 2-18 years

An expert panel of India's central drug authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain......

Human trials of India's 1st mRNA vaccine to start in February

The country's first messenger mRNA vaccine is expected to begin trials on humans in February. IMAGE: A health worker administers a dose of COVID-19 vaccine to a beneficiary during a vaccination......

Govt denies pressuring Covaxin makers for early release of vaccine

The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.......

Quality Lapses Shut Down Drug Makers

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Subject Expert Committee Of The Central Drugs Standard Control Organisation

News for Subject Expert Committee Of The Central Drugs Standard Control Organisation

Bharat Biotech's Covaxin vaccine cleared by special panel

DCGI approves market authorisation for Covovax as Covid booster dose

Covaxin recommended by expert panel for 2-18 years

Human trials of India's 1st mRNA vaccine to start in February

Govt denies pressuring Covaxin makers for early release of vaccine

Quality Lapses Shut Down Drug Makers

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS